These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8877390)

  • 21. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
    Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K
    J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
    Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
    Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
    Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of tolerance inducibility to class I or class II antigens between cyclophosphamide (CP)-induced tolerance and transfusion with donor cells: general effectiveness of CP-induced tolerance and difference of skin graft prolongation in each class I antigen-disparate combination.
    Tomita Y; Nomoto K
    Immunobiology; 1992 Nov; 186(3-4):282-91. PubMed ID: 1490733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent tolerance induced after portal venous injection of allogeneic cells plus cyclophosphamide treatment.
    Jin T; Sugiura K; Ishikawa J; Lee S; Morita H; Nagahama T; Ikehara S
    Immunobiology; 1999 Jun; 200(2):215-26. PubMed ID: 10416129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance.
    Tomita Y; Nomoto K
    Immunobiology; 1990 Nov; 181(4-5):430-7. PubMed ID: 2099910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats.
    Eto M; Nishimura Y; Matsuo K; Omoto K; Goto K; Kumuzawa J; Nomoto K
    J Urol; 1995 May; 153(5):1693-6. PubMed ID: 7715012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological tolerance to xenogeneic grafts induced by cyclophosphamide in adult animals.
    Chernyakhovskaya IYu ; Fontalin LN
    Folia Biol (Praha); 1994; 40(6):371-80. PubMed ID: 7589696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2, a pro-autoimmune lymphokine that interferes with post-deletional tolerance.
    Kroemer G; Martínez C
    Semin Immunol; 1992 Jun; 4(3):167-79. PubMed ID: 1627788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance.
    Remuzzi G
    Am J Kidney Dis; 1998 Feb; 31(2):197-212. PubMed ID: 9469488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.